Background
It is known that the transforming growth factor beta (TGF-β) can act as both a tumor suppressor and as a significant stimulator of tumor progression, invasion, and metastasis. It has been suggested a link between TGF-β and CXCR4 expression in human breast cancer cells, which may be one of the mechanisms of TGF-β mediated enhancement of metastatic potential in breast cancer cells. Therefore, the objective of the present study was to investigate the TGF-β T869C polymorphism and its expression correlated with CXCR4 expression in breast cancer patients.
Patients and methods
Genomic DNA was obtained from 21 samples of peripheral blood or from normal tissue previously fixed in formalin and embedded in paraffin for TGF-β T869C polymorphism analyses. Total cellular RNA was extracted from the same 21 patients, but from fresh tissue (tumor and adjacent healthy from the same breast) to expression analysis by Real Time PCR.
Results
No significant differences were observed in genotype distribution according to clinic pathological characteristics. TGF-β mRNA expression was assessed according to T869C polymorphism and CC patients presented a higher TGF-β expression but not significant when compared to other genotypes (p=0.064). A positive correlation was observed in relative mRNA expressions of CXCR4 and TGF-β (p= 0.020). It is known that overexpression of TGF-β by both tumor and stromal tissue can facilitate the development of metastases, mainly by TGF-β stimulated angiogenesis and increased tumor cell motility.
Conclusion
Our findings suggested a role of these genes as progression markers for breast carcinoma.
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